Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Doxorubicin Hydrochloride Pegylated Liposomal Injection 20 mg
  Indications :
 

Ovarian carcinoma

Breast cancer

AIDS related kaposi's sarcoma

Multiple Myeloma
   
  Dosage :
  The common dosage schedule is 60-75 mg/m2 as a single intravenous injection administered every 3 weeks.

Dosage Adjustment :

Renal Impairment : Not necessary.

Hepatic Impairment : Required.
   
  Packing : 5 Vials of 20 mg
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.